Monday, September 9, 2019

NervGen Pharma Trials and Scar Tissue

For readers who are watching NervGen Pharma, here's an update on upcoming trials for people with spinal cord injuries and multiple sclerosis.  If you're new to NervGen, they're working on a peptide (NVG-291) that will allow nerve regeneration in spite of scar tissue.  You can read more about NervGen and NVG-291 here
I've talked about scar tissue and various treatments of it several times before: using an EpiPen for SCIs, eating blue M&Ms (yes, M&Ms), injecting nanoparticles, and inserting an internal scaffolding.  All of these different methods tackle the situation of scar tissue which blocks regeneration.  The blue M&M seems like it would be most popular, and I'm keeping an eye on it . . . but it's not that simple!  Caveat lector. 

No comments:

Post a Comment